Published in Mol Pharm on June 04, 2009
Stimuli-responsive nanocarriers for drug delivery. Nat Mater (2013) 3.52
RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol (2010) 1.80
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov (2014) 1.61
Poly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery. Mol Ther (2010) 1.01
A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems. Biomaterials (2009) 1.00
Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections. Theranostics (2014) 0.96
Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials (2010) 0.94
Bioreducible polycations in nucleic acid delivery: past, present, and future trends. Macromol Biosci (2014) 0.93
Stimulus-responsive nanopreparations for tumor targeting. Integr Biol (Camb) (2013) 0.91
Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor. Biomaterials (2014) 0.88
Reducible poly(amido ethylenimine)-based gene delivery system for improved nucleus trafficking of plasmid DNA. Bioconjug Chem (2010) 0.87
Bioreducible polymers for therapeutic gene delivery. J Control Release (2014) 0.87
Enhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells. Mol Pharm (2013) 0.86
Ultrasound-assisted siRNA delivery via arginine-grafted bioreducible polymer and microbubbles targeting VEGF for ovarian cancer treatment. J Control Release (2014) 0.85
Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system. J Control Release (2011) 0.83
A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid. Int J Nanomedicine (2012) 0.82
Development of protein mimics for intracellular delivery. Biopolymers (2015) 0.81
Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells. Biomacromolecules (2015) 0.80
Light-mediated activation of siRNA Release in diblock copolymer assemblies for controlled gene silencing. Adv Healthc Mater (2014) 0.80
Optimal Hydrophobicity in Ring-Opening Metathesis Polymerization-Based Protein Mimics Required for siRNA Internalization. Biomacromolecules (2016) 0.79
Development of streptavidin-based nanocomplex for siRNA delivery. Mol Pharm (2013) 0.79
In Vivo Delivery of RNAi by Reducible Interfering Nanoparticles (iNOPs). ACS Med Chem Lett (2013) 0.77
siRNA Delivery by Stimuli-Sensitive Nanocarriers. Curr Pharm Des (2015) 0.76
Mapping Optimal Charge Density and Length of ROMP-Based PTDMs for siRNA Internalization. Biomacromolecules (2016) 0.75
Folic Acid-Decorated Polyamidoamine Dendrimer Exhibits High Tumor Uptake and Sustained Highly Localized Retention in Solid Tumors: Its Utility for Local siRNA Delivery. Acta Biomater (2017) 0.75
Photocrosslinkable, biodegradable hydrogels with controlled cell adhesivity for prolonged siRNA delivery to hMSCs to enhance their osteogenic differentiation. J Mater Chem B Mater Biol Med (2016) 0.75
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol (2004) 10.55
Gene silencing in mammals by small interfering RNAs. Nat Rev Genet (2002) 7.80
Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet (2001) 5.84
siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov (2004) 4.73
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials (2003) 4.26
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm (2006) 2.28
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release (2008) 2.15
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem (2001) 2.06
A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res (2005) 1.81
Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther (2006) 1.79
Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release (2007) 1.79
Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem (2006) 1.77
Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc (2005) 1.66
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release (2006) 1.44
Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem (2008) 1.43
Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release (2004) 1.43
Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev (1998) 1.38
Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials (2007) 1.35
Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release (2004) 1.34
Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol (1998) 1.31
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release (2007) 1.02
Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol Pharm (2008) 0.99
Membrane permeability commonly shared among arginine-rich peptides. J Mol Recognit (2003) 0.98
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction. J Control Release (2008) 0.96
Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Biomaterials (2008) 0.92
Co-operative effect of glutathione depletion and selenium induced oxidative stress on API and NFkB expression in testicular cells in vitro: insights to regulation of spermatogenesis. Biol Res (2008) 0.89
Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells. Biochimie (2007) 0.88
A facile entrapment approach to construct PEGylated polyplexes for improving stability in physiological condition. Colloids Surf B Biointerfaces (2007) 0.87
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Epidermal electronics. Science (2011) 8.65
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell (2008) 4.32
Current status of polymeric gene delivery systems. Adv Drug Deliv Rev (2006) 3.04
Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg (2003) 2.73
Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2005) 2.62
Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev (2002) 2.54
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release (2008) 2.15
A flexible and highly sensitive strain-gauge sensor using reversible interlocking of nanofibres. Nat Mater (2012) 2.09
Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant (2009) 1.91
Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res (2005) 1.91
Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther (2006) 1.79
Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem (2006) 1.77
In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release (2008) 1.67
Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int (2004) 1.56
Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials (2008) 1.55
Validation of a multi-frequency electrical impedance tomography (mfEIT) system KHU Mark1: impedance spectroscopy and time-difference imaging. Physiol Meas (2008) 1.50
Efficient siRNA delivery with non-viral polymeric vehicles. Pharm Res (2008) 1.46
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release (2006) 1.44
Multilevel surgery in patients with rapid eye movement-related obstructive sleep apnea. Otolaryngol Head Neck Surg (2009) 1.43
Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem (2008) 1.43
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail (2012) 1.43
Magnetic resonance imaging (MRI) assessment of ventricular remodeling after myocardial infarction in rabbits. Comp Med (2012) 1.42
Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release (2004) 1.34
Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir (2005) 1.32
A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells. Biol Pharm Bull (2007) 1.31
Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg (2007) 1.25
Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res (2005) 1.20
Role of oxidative stress in epileptic seizures. Neurochem Int (2011) 1.20
Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release (2002) 1.19
Effects of PEG conjugation on insulin properties. Adv Drug Deliv Rev (2002) 1.18
Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules (2002) 1.12
An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol Ther (2002) 1.11
A family of bioreducible poly(disulfide amine)s for gene delivery. Biomaterials (2009) 1.10
Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training. J Thorac Cardiovasc Surg (2009) 1.10
Novel pH sensitive block copolymer micelles for solvent free drug loading. Macromol Biosci (2006) 1.08
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
Evolution of oncolytic adenovirus for cancer treatment. Adv Drug Deliv Rev (2011) 1.04
The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials (2009) 1.04
Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy. J Control Release (2007) 1.02
Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease. Pharm Res (2004) 1.01
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. J Control Release (2005) 1.01
A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems. Biomaterials (2009) 1.00
Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes. Mol Ther (2005) 0.99
Ligation of the left circumflex coronary artery with subsequent MRI and histopathology in rabbits. J Am Assoc Lab Anim Sci (2010) 0.98
Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin. Biomaterials (2004) 0.97
Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrier. J Control Release (2004) 0.97
Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem (2006) 0.97
Mixtures of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)-g-poly(ethylene glycol) for improved gene delivery. Bioconjug Chem (2010) 0.97
Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjug Chem (2003) 0.96
A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J Control Release (2003) 0.96
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction. J Control Release (2008) 0.96
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials (2010) 0.96
Caprolactonic poloxamer analog: PEG-PCL-PEG. Biomacromolecules (2005) 0.96
Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA. Biomaterials (2011) 0.96
GLP-1 gene delivery for the treatment of type 2 diabetes. Mol Ther (2003) 0.95
Feasibility of breast cancer lesion detection using a multi-frequency trans-admittance scanner (TAS) with 10 Hz to 500 kHz bandwidth. Physiol Meas (2007) 0.95
Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery. Biomaterials (2011) 0.95
Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J Control Release (2002) 0.94
Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. Bioconjug Chem (2003) 0.94
Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J Gene Med (2003) 0.94
Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials (2010) 0.94
Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system. Spine (Phila Pa 1976) (2005) 0.94
LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem (2008) 0.93
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant (2009) 0.93
Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Biomaterials (2008) 0.92
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Mol Ther (2004) 0.92
Hydrogen peroxide-induced extracellular signal-regulated kinase activation in cultured feline ileal smooth muscle cells. J Pharmacol Exp Ther (2004) 0.92
PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J Control Release (2002) 0.92
Dendrimer type bio-reducible polymer for efficient gene delivery. J Control Release (2012) 0.92
Efficient gene expression system using the RTP801 promoter in the corpus cavernosum of high-cholesterol diet-induced erectile dysfunction rats for gene therapy. J Sex Med (2008) 0.91
Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin. Biomaterials (2011) 0.91
Analysis of preload-dependent reversible mechanical interlocking using beetle-inspired wing locking device. Langmuir (2011) 0.91
Postoperative pericardial adhesion prevention using Carbylan-SX in a rabbit model. J Surg Res (2007) 0.91
Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules (2005) 0.90
A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution. Pharm Res (2005) 0.90
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials (2011) 0.90
Changes in histological features of nasal polyps in a Korean population over a 17-year period. Otolaryngol Head Neck Surg (2013) 0.90
Intracellular kinetics of non-viral gene delivery using polyethylenimine carriers. Pharm Res (2007) 0.90
Metabolically active human brown adipose tissue derived stem cells. Stem Cells (2014) 0.90